1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002 Jun 19;39(12):1890-900. https://doi.org/10.1016/s0735-1097(02)01886-7
2. Butera G, Chessa M, Carminati M. Percutaneous closure of ventricular septal defects. State of the art. J Cardiovasc Med (Hagerstown). 2007 Jan;8(1):39-45. https://doi.org/10.2459/01.jcm.00
00247434.59451.d7
3. Narin N, Baykan A, Argun M, Ozyurt A, Pamukcu O, Bayram A, Uzum K. New modified balloon-assisted technique to provide appropriate deployment in the closure of large secundum atrial septal defect using amplatzer septal occluder in children. J Invasive Cardiol. 2014 Nov;26(11):597-602.
4. Allen HD, Driscoll DJ, Shaddy RE, Feltes TF, editors. Moss & Adams’ Heart Disease in Infants, Children, and Adolescents, Including the Fetus and Young Adult. 10th ed. Philadelphia: Wolters Kluwer; 2022.
5. World Health Organization. WHO Child Growth Standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development. Geneva: World Health Organization; 2006.
6. Alshahrani D, Linnane N, McCrossan B, Oslizlok P, McMahon CJ, Walsh KP, et al. Transfemoral Perimembranous Ventricular Septal Defect Device Closure in Infants Weighing ≤ 10 kg. Pediatr Cardiol. 2023 Jun;44(5):1176-82. https://doi.org/10.1007/s00246-023-03100-5
7. Taşcı O, Pamukçu Ö, Narin N, et al. The Effect of Transcatheter Ventricular Septal Defect Closure on Children’s Appetite and Growth: A Single-Center Experience. Erciyes Med J. 2023;45(2):145-51. https://dx.doi.org/10.14744/etd.2022.41848
8. Munde K, Munde A, Paliwal M, et al. Percutaneous device closure of a perimembranous ventricular septal defect in an infant weighing less than 5 kg. AsiaIntervention. 2025;11(1):90-92. https://dx.doi.org/10.4244/AIJ-D-24-00038